Products
16415 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Newmont Constant Leverage with ISIN code: CH1595934543 | Newmont | Constant Leverage | Short | ― | 115.521 | 7.76 | 0.020 | 7.78 | 1 | -0.26% | 18.84% | 53.97% | 18 Aug. 2026 | |
| Nike Constant Leverage with ISIN code: CH1470667853 | Nike | Constant Leverage | Long | ― | 33.883 | 0.38 | 0.010 | 0.39 | 1 | -2.56% | -40.63% | -72.06% | 5 Jun. 2026 | |
| Nike Constant Leverage with ISIN code: CH1470667846 | Nike | Constant Leverage | Long | ― | 33.883 | 1.03 | 0.010 | 1.04 | 1 | -0.96% | -30.87% | -59.29% | 5 Jun. 2026 | |
| Nike Constant Leverage with ISIN code: CH1470667838 | Nike | Constant Leverage | Short | ― | 33.883 | 17.6 | 0.090 | 17.69 | 1 | -0.51% | 32.03% | 105.85% | 5 Jun. 2026 | |
| Nike Constant Leverage with ISIN code: CH1119067994 | Nike | Constant Leverage | Short | ― | 33.883 | 2.74 | 0.010 | 2.75 | 1 | -0.36% | 21.24% | 67.07% | 12 May. 2022 | |
| Nokia Constant Leverage with ISIN code: CH1119067226 | Nokia | Constant Leverage | Long | ― | 9.462 | 2.16 | 0.030 | 2.19 | 1 | -1.37% | 6.40% | 26.32% | 6 May. 2022 | |
| Nokia Constant Leverage with ISIN code: CH1450969105 | Nokia | Constant Leverage | Long | ― | 9.462 | 0.38 | 0.030 | 0.41 | 1 | -7.32% | 2.70% | -32.14% | 21 Aug. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587271 | Novartis | Constant Leverage | Long | ― | 116.734 | 11.81 | 0.110 | 11.92 | 1 | -0.92% | -12.26% | -45.88% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587297 | Novartis | Constant Leverage | Long | ― | 116.734 | 0.84 | 0.030 | 0.87 | 1 | -3.45% | -25.66% | -88.71% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587289 | Novartis | Constant Leverage | Long | ― | 116.734 | 5.23 | 0.070 | 5.3 | 1 | -1.32% | -17.90% | -67.80% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587305 | Novartis | Constant Leverage | Long | ― | 116.734 | 0.11 | 0.030 | 0.14 | 1 | -21.43% | -42.11% | -94.39% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416671 | Novartis | Constant Leverage | Long | ― | 116.734 | 1.42 | ― | ― | 1 | 0.00% | -34.86% | -93.76% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1470667580 | Novartis | Constant Leverage | Short | ― | 116.734 | 1.02 | 0.030 | 1.05 | 1 | -2.86% | 34.21% | 75.86% | 5 Jun. 2026 | |
| Novartis Constant Leverage with ISIN code: CH1595935060 | Novartis | Constant Leverage | Short | ― | 116.734 | 6.16 | 0.110 | 6.27 | 1 | -1.75% | 24.19% | 71.59% | 18 Aug. 2026 | |
| Novartis Constant Leverage with ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 116.734 | 0.53 | 0.030 | 0.56 | 1 | -5.36% | 3.92% | 29.27% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1470667598 | Novartis | Constant Leverage | Short | ― | 116.734 | 3.43 | 0.060 | 3.49 | 1 | -1.72% | 19.51% | 64.90% | 5 Jun. 2026 | |
| Novartis Constant Leverage with ISIN code: CH1595935078 | Novartis | Constant Leverage | Short | ― | 116.734 | 9.35 | 0.100 | 9.45 | 1 | -1.06% | 15.15% | 52.78% | 18 Aug. 2026 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1595934220 | Novo Nordisk | Constant Leverage | Long | ― | 247.331 | 3.48 | 0.070 | 3.55 | 1 | -1.97% | -17.54% | -77.31% | 18 Aug. 2026 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968479 | Novo Nordisk | Constant Leverage | Long | ― | 247.331 | 0.47 | 0.030 | 0.5 | 1 | -6.00% | -17.54% | -62.40% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587321 | Novo Nordisk | Constant Leverage | Short | ― | 247.331 | 2.75 | 0.030 | 2.78 | 1 | -1.08% | 8.27% | 105.22% | 13 Oct. 2023 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.